AAC -- Table of Contents (November 1 2009, 53 [11])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Cover Image

Other Issues

Contents: November 2009, Volume 53, Issue 11

       Commentary

       Minireviews

       Mechanisms of Resistance

       Analytical Procedures

       Mechanisms of Action

       Chemistry; Biosynthesis

       Antiviral Agents

       Experimental Therapeutics

       Pharmacology

       Susceptibility

       Clinical Therapeutics

       Letters

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

[Index by Author]

Table of Contents (PDF) » | Masthead (PDF) »

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Commentary:

Reconsidering Some Approved Antimicrobial Agents for Tuberculosis
Lowell S. Young
Antimicrob. Agents Chemother. November 2009 53: 4577-4579; published ahead of print September 8, 2009, doi:10.1128/AAC.00887-09
[Full Text] [PDF] [Reprints and Permissions] FREE

Minireviews:

VanA-Type Vancomycin-Resistant Staphylococcus aureus
Bruno Périchon and Patrice Courvalin
Antimicrob. Agents Chemother. November 2009 53: 4580-4587; published ahead of print June 8, 2009, doi:10.1128/AAC.00346-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Mechanisms of Resistance:

Plasmodium falciparum Drug Resistance in Madagascar: Facing the Spread of Unusual pfdhfr and pfmdr-1 Haplotypes and the Decrease of Dihydroartemisinin Susceptibility
Valérie Andriantsoanirina, Arsène Ratsimbasoa, Christiane Bouchier, Martial Jahevitra, Stéphane Rabearimanana, Rogelin Radrianjafy, Voahangy Andrianaranjaka, Tantely Randriantsoa, Marie Ange Rason, Magali Tichit, Léon Paul Rabarijaona, Odile Mercereau-Puijalon, Rémy Durand, and Didier Ménard
Antimicrob. Agents Chemother. November 2009 53: 4588-4597; published ahead of print August 24, 2009, doi:10.1128/AAC.00610-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Horizontal Transfer of Tetracycline Resistance among Chlamydia spp. In Vitro
R. J. Suchland, K. M. Sandoz, B. M. Jeffrey, W. E. Stamm, and D. D. Rockey
Antimicrob. Agents Chemother. November 2009 53: 4604-4611; published ahead of print August 17, 2009, doi:10.1128/AAC.00477-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Induction of Multidrug Resistance Mechanism in Escherichia coli Biofilms by Interplay between Tetracycline and Ampicillin Resistance Genes
Thithiwat May, Akinobu Ito, and Satoshi Okabe
Antimicrob. Agents Chemother. November 2009 53: 4628-4639; published ahead of print August 31, 2009, doi:10.1128/AAC.00454-09
[Abstract] [Full Text] [PDF] [Supplemental material] [Reprints and Permissions]

Two Distinct Major Facilitator Superfamily Drug Efflux Pumps Mediate Chloramphenicol Resistance in Streptomyces coelicolor
James J. Vecchione, Blair Alexander, Jr., and Jason K. Sello
Antimicrob. Agents Chemother. November 2009 53: 4673-4677; published ahead of print August 17, 2009, doi:10.1128/AAC.00853-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

A Ser29Leu Substitution in the Cytosine Deaminase Fca1p Is Responsible for Clade-Specific Flucytosine Resistance in Candida dubliniensis
Brenda A. McManus, Gary P. Moran, Judy A. Higgins, Derek J. Sullivan, and David C. Coleman
Antimicrob. Agents Chemother. November 2009 53: 4678-4685; published ahead of print August 24, 2009, doi:10.1128/AAC.00607-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania
Hanna E. Sidjabat, David L. Paterson, Jennifer M. Adams-Haduch, Lindsay Ewan, Anthony W. Pasculle, Carlene A. Muto, Guo-Bao Tian, and Yohei Doi
Antimicrob. Agents Chemother. November 2009 53: 4733-4739; published ahead of print August 17, 2009, doi:10.1128/AAC.00533-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
José-Manuel Rodríguez-Martínez, Laurent Poirel, and Patrice Nordmann
Antimicrob. Agents Chemother. November 2009 53: 4783-4788; published ahead of print September 8, 2009, doi:10.1128/AAC.00574-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in Vietnam
Duong Duy An, Nguyen Thi Hong Duyen, Nguyen Thi Ngoc Lan, Dai Viet Hoa, Dang Thi Minh Ha, Vo Sy Kiet, Do Dang Anh Thu, Nguyen Van Vinh Chau, Nguyen Huy Dung, Dinh Ngoc Sy, Jeremy Farrar, and Maxine Caws
Antimicrob. Agents Chemother. November 2009 53: 4835-4839; published ahead of print August 31, 2009, doi:10.1128/AAC.00541-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Rapid Detection of a Point Mutation in the parC Gene Associated with Decreased Susceptibility to Fluoroquinolones in Mycoplasma bovis
I. Lysnyansky, I. Mikula, I. Gerchman, and S. Levisohn
Antimicrob. Agents Chemother. November 2009 53: 4911-4914; published ahead of print August 31, 2009, doi:10.1128/AAC.00703-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain
Esther Viedma, Carlos Juan, Joshi Acosta, Laura Zamorano, Joaquín R. Otero, Francisca Sanz, Fernando Chaves, and Antonio Oliver
Antimicrob. Agents Chemother. November 2009 53: 4930-4933; published ahead of print September 8, 2009, doi:10.1128/AAC.00900-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

ISCR2, Another Vehicle for bla_VEB Gene Acquisition
Laurent Poirel, Pauline D. Mugnier, Mark A. Toleman, Timothy R. Walsh, Melina J. Rapoport, Alejandro Petroni, and Patrice Nordmann
Antimicrob. Agents Chemother. November 2009 53: 4940-4943; published ahead of print August 24, 2009, doi:10.1128/AAC.00414-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Combined Inactivation of lon and ycgE Decreases Multidrug Susceptibility by Reducing the Amount of OmpF Porin in Escherichia coli
Valérie Duval, Hervé Nicoloff, and Stuart B. Levy
Antimicrob. Agents Chemother. November 2009 53: 4944-4948; published ahead of print August 31, 2009, doi:10.1128/AAC.00787-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Analytical Procedures:

New Approach for Drug Susceptibility Testing: Monitoring the Stress Response of Mycobacteria
Ronald J. Rieder, Zhihui Zhao, and Boris Zavizion
Antimicrob. Agents Chemother. November 2009 53: 4598-4603; published ahead of print August 24, 2009, doi:10.1128/AAC.00643-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Mechanisms of Action:

Interaction of Aminoglycosides with Human Mitochondrial 12S rRNA Carrying the Deafness-Associated Mutation
Yaping Qian and Min-Xin Guan
Antimicrob. Agents Chemother. November 2009 53: 4612-4618; published ahead of print August 17, 2009, doi:10.1128/AAC.00965-08
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Primary Structure and Antibacterial Activity of Chicken Bone Marrow-Derived β-Defensins
Chrystelle Derache, Valérie Labas, Vincent Aucagne, Hervé Meudal, Céline Landon, Agnès F. Delmas, Thierry Magallon, and Anne-Christine Lalmanach
Antimicrob. Agents Chemother. November 2009 53: 4647-4655; published ahead of print September 8, 2009, doi:10.1128/AAC.00301-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

The Large Mechanosensitive Channel MscL Determines Bacterial Susceptibility to the Bacteriocin Sublancin 168
Thijs R. H. M. Kouwen, Erik N. Trip, Emma L. Denham, Mark J. J. B. Sibbald, Jean-Yves F. Dubois, and Jan Maarten van Dijl
Antimicrob. Agents Chemother. November 2009 53: 4702-4711; published ahead of print September 8, 2009, doi:10.1128/AAC.00439-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Quorum-Quenching Acylase Reduces the Virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans Infection Model
Evelina Papaioannou, Mariana Wahjudi, Pol Nadal-Jimenez, Gudrun Koch, Rita Setroikromo, and Wim J. Quax
Antimicrob. Agents Chemother. November 2009 53: 4891-4897; published ahead of print August 31, 2009, doi:10.1128/AAC.00380-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Chemistry; Biosynthesis:

Characterization of Two Seryl-tRNA Synthetases in Albomycin-Producing Streptomyces sp. Strain ATCC 700974
Yu Zeng, Hervé Roy, Preeti B. Patil, Michael Ibba, and Shawn Chen
Antimicrob. Agents Chemother. November 2009 53: 4619-4627; published ahead of print August 31, 2009, doi:10.1128/AAC.00782-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Antiviral Agents:

Impact of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations P119S and T165A on 4'-Ethynylthymidine Analog Resistance Profile
Guangwei Yang, Elijah Paintsil, Ginger E. Dutschman, Susan P. Grill, Chuan-Jen Wang, Jimin Wang, Hiromichi Tanaka, Takayuki Hamasaki, Masanori Baba, and Yung-Chi Cheng
Antimicrob. Agents Chemother. November 2009 53: 4640-4646; published ahead of print August 24, 2009, doi:10.1128/AAC.00686-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

LFA-1 Antagonists as Agents Limiting Human Immunodeficiency Virus Type 1 Infection and Transmission and Potentiating the Effect of the Fusion Inhibitor T-20
Mélanie R. Tardif, Caroline Gilbert, Sandra Thibault, Jean-François Fortin, and Michel J. Tremblay
Antimicrob. Agents Chemother. November 2009 53: 4656-4666; published ahead of print August 31, 2009, doi:10.1128/AAC.00117-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Human Immunodeficiency Virus Type 1 Recombinant Reverse Transcriptase Enzymes Containing the G190A and Y181C Resistance Mutations Remain Sensitive to Etravirine
Hongtao Xu, Yudong Quan, Bluma G. Brenner, Tamara Bar-Magen, Maureen Oliveira, Susan M. Schader, and Mark A. Wainberg
Antimicrob. Agents Chemother. November 2009 53: 4667-4672; published ahead of print August 24, 2009, doi:10.1128/AAC.00800-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Comparison of Human Immunodeficiency Virus Type 1 Tropism Profiles in Clinical Samples by the Trofile and MT-2 Assays
Eoin Coakley, Jacqueline D. Reeves, Wei Huang, Marga Mangas-Ruiz, Irma Maurer, Agnes M. Harskamp, Soumi Gupta, Yolanda Lie, Christos J. Petropoulos, Hanneke Schuitemaker, and Angélique B. van 't Wout
Antimicrob. Agents Chemother. November 2009 53: 4686-4693; published ahead of print August 17, 2009, doi:10.1128/AAC.00229-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Inhibition of Envelope-Mediated CD4⁺-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
Louis Alexander, Sharon Zhang, Brian McAuliffe, David Connors, Nannon Zhou, Tao Wang, Michele Agler, John Kadow, and Pin-Fang Lin
Antimicrob. Agents Chemother. November 2009 53: 4726-4732; published ahead of print August 31, 2009, doi:10.1128/AAC.00494-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection
Kao-Lu Pan, Jin-Ching Lee, Hsing-Wen Sung, Teng-Yuang Chang, and John T.-A. Hsu
Antimicrob. Agents Chemother. November 2009 53: 4825-4834; published ahead of print August 31, 2009, doi:10.1128/AAC.00601-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory Tract
Kumiko Koyama, Makoto Takahashi, Masataka Oitate, Naoko Nakai, Hideo Takakusa, Shin-ichi Miura, and Osamu Okazaki
Antimicrob. Agents Chemother. November 2009 53: 4845-4851; published ahead of print August 17, 2009, doi:10.1128/AAC.00731-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

The Phthalocyanine Prototype Derivative Alcian Blue Is the First Synthetic Agent with Selective Anti-Human Immunodeficiency Virus Activity Due to Its gp120 Glycan-Binding Potential
Katrien O. François, Christophe Pannecouque, Joeri Auwerx, Virginia Lozano, Maria-Jésus Pérez-Pérez, Dominique Schols, and Jan Balzarini
Antimicrob. Agents Chemother. November 2009 53: 4852-4859; published ahead of print August 31, 2009, doi:10.1128/AAC.00811-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
Rajin Shahriar, Soo-Yon Rhee, Tommy F. Liu, W. Jeffrey Fessel, Anthony Scarsella, William Towner, Susan P. Holmes, Andrew R. Zolopa, and Robert W. Shafer
Antimicrob. Agents Chemother. November 2009 53: 4869-4878; published ahead of print August 31, 2009, doi:10.1128/AAC.00592-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Experimental Therapeutics:

Pharmacological Inhibition of Transforming Growth Factor β Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease
Mariana C. Waghabi, Elen M. de Souza, Gabriel M. de Oliveira, Michelle Keramidas, Jean-Jacques Feige, Tania C. Araújo-Jorge, and Sabine Bailly
Antimicrob. Agents Chemother. November 2009 53: 4694-4701; published ahead of print September 8, 2009, doi:10.1128/AAC.00580-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model
Céline Vidaillac, Steve N. Leonard, and Michael J. Rybak
Antimicrob. Agents Chemother. November 2009 53: 4712-4717; published ahead of print September 8, 2009, doi:10.1128/AAC.00636-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Impact of Spore Biology on the Rate of Kill and Suppression of Resistance in Bacillus anthracis
G. L. Drusano, O. O. Okusanya, A. O. Okusanya, B. van Scoy, D. L. Brown, C. Fregeau, R. Kulawy, M. Kinzig, F. Sörgel, H. S. Heine, and A. Louie
Antimicrob. Agents Chemother. November 2009 53: 4718-4725; published ahead of print August 17, 2009, doi:10.1128/AAC.00802-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Influence of Inoculum Size and Marbofloxacin Plasma Exposure on the Amplification of Resistant Subpopulations of Klebsiella pneumoniae in a Rat Lung Infection Model
Anne-Sylvie Kesteman, Aude A. Ferran, Agnès Perrin-Guyomard, Michel Laurentie, Pascal Sanders, Pierre-Louis Toutain, and Alain Bousquet-Mélou
Antimicrob. Agents Chemother. November 2009 53: 4740-4748; published ahead of print September 8, 2009, doi:10.1128/AAC.00608-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Influence of Antidrug Antibodies on Plectasin Efficacy and Pharmacokinetics
Karoline Sidelmann Brinch, Niels Frimodt-Møller, Niels Høiby, and Hans-Henrik Kristensen
Antimicrob. Agents Chemother. November 2009 53: 4794-4800; published ahead of print August 17, 2009, doi:10.1128/AAC.00440-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Plectasin Shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in a Mouse Peritonitis Model
Karoline Sidelmann Brinch, Anne Sandberg, Pierre Baudoux, Françoise Van Bambeke, Paul M. Tulkens, Niels Frimodt-Møller, Niels Høiby, and Hans-Henrik Kristensen
Antimicrob. Agents Chemother. November 2009 53: 4801-4808; published ahead of print September 8, 2009, doi:10.1128/AAC.00685-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Radiolabeled Antibodies to Bacillus anthracis Toxins Are Bactericidal and Partially Therapeutic in Experimental Murine Anthrax
Johanna Rivera, Antonio S. Nakouzi, Alfred Morgenstern, Frank Bruchertseifer, Ekaterina Dadachova, and Arturo Casadevall
Antimicrob. Agents Chemother. November 2009 53: 4860-4868; published ahead of print August 24, 2009, doi:10.1128/AAC.01269-08
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Noninvasive Pulmonary [¹⁸F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment
Stephanie L. Davis, Eric L. Nuermberger, Peter K. Um, Camille Vidal, Bruno Jedynak, Martin G. Pomper, William R. Bishai, and Sanjay K. Jain
Antimicrob. Agents Chemother. November 2009 53: 4879-4884; published ahead of print September 8, 2009, doi:10.1128/AAC.00789-09
[Abstract] [Full Text] [PDF] [Supplemental material] [Reprints and Permissions]

Tooth-Binding Micelles for Dental Caries Prevention
Fu Chen, Xin-Ming Liu, Kelly C. Rice, Xue Li, Fang Yu, Richard A. Reinhardt, Kenneth W. Bayles, and Dong Wang
Antimicrob. Agents Chemother. November 2009 53: 4898-4902; published ahead of print August 24, 2009, doi:10.1128/AAC.00387-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal
Nacer Lounis, Tom Gevers, Joke Van Den Berg, Luc Vranckx, and Koen Andries
Antimicrob. Agents Chemother. November 2009 53: 4927-4929; published ahead of print September 8, 2009, doi:10.1128/AAC.00689-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Pharmacology:

Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers
Gopal Krishna, Lei Ma, Donna Vickery, Xin Yu, Irene Wu, Edward Power, Eric Beresford, and Steven Komjathy
Antimicrob. Agents Chemother. November 2009 53: 4749-4752; published ahead of print September 8, 2009, doi:10.1128/AAC.00889-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Nonclinical Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in the Central Nervous System
Gerhard Hoffmann, Christoph Funk, Stephen Fowler, Michael B. Otteneder, Alexander Breidenbach, Craig R. Rayner, Tom Chu, and Eric P. Prinssen
Antimicrob. Agents Chemother. November 2009 53: 4753-4761; published ahead of print August 31, 2009, doi:10.1128/AAC.01541-08
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus
A. Caldés, H. Colom, Y. Armendariz, M. J. Garrido, I. F. Troconiz, S. Gil-Vernet, N. Lloberas, L. Pou, C. Peraire, and J. M. Grinyó
Antimicrob. Agents Chemother. November 2009 53: 4816-4824; published ahead of print September 8, 2009, doi:10.1128/AAC.00085-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Lack of Effect of Efavirenz on the Pharmacokinetics of Tipranavir-Ritonavir in Healthy Volunteers
C. J. L. la Porte, J. P. Sabo, L. Béïque, and D. W. Cameron
Antimicrob. Agents Chemother. November 2009 53: 4840-4844; published ahead of print August 31, 2009, doi:10.1128/AAC.00462-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
A. Schmitt-Hoffmann, B. Roos, J. Spickermann, M. Heep, É. Peterfaí, D. J. Edwards, and K. Stoeckel
Antimicrob. Agents Chemother. November 2009 53: 4885-4890; published ahead of print August 10, 2009, doi:10.1128/AAC.00319-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Penetration of Colistin into Cerebrospinal Fluid
S. L. Markantonis, N. Markou, M. Fousteri, N. Sakellaridis, S. Karatzas, I. Alamanos, E. Dimopoulou, and G. Baltopoulos
Antimicrob. Agents Chemother. November 2009 53: 4907-4910; published ahead of print August 24, 2009, doi:10.1128/AAC.00345-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations
Stefan Weiler, Gerda Falkensammer, Angelika Hammerer-Lercher, Markus Anliker, Helene Vogelsinger, Michael Joannidis, Stefan Dunzendorfer, Markus Stein, and Romuald Bellmann
Antimicrob. Agents Chemother. November 2009 53: 4934-4937; published ahead of print August 24, 2009, doi:10.1128/AAC.00796-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Susceptibility:

Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
Francis F. Arhin, Deborah C. Draghi, Chris M. Pillar, Thomas R. Parr, Jr., Gregory Moeck, and Daniel F. Sahm
Antimicrob. Agents Chemother. November 2009 53: 4762-4771; published ahead of print September 8, 2009, doi:10.1128/AAC.00952-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Tuberculosis and Trimethoprim-Sulfamethoxazole
Pierre Forgacs, Nancy L. Wengenack, Leslie Hall, Sarah K. Zimmerman, Mark L. Silverman, and Glenn D. Roberts
Antimicrob. Agents Chemother. November 2009 53: 4789-4793; published ahead of print June 29, 2009, doi:10.1128/AAC.01658-08
[Abstract] [Full Text] [PDF] [Reprints and Permissions] FREE

In Vitro Activities of Trioxaquines against Schistosoma mansoni
Jérôme Boissier, Frédéric Coslédan, Anne Robert, and Bernard Meunier
Antimicrob. Agents Chemother. November 2009 53: 4903-4906; published ahead of print July 13, 2009, doi:10.1128/AAC.00640-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
Heather J. Adam, Nancy M. Laing, C. Richard King, Ben Lulashnyk, Daryl J. Hoban, and George G. Zhanel
Antimicrob. Agents Chemother. November 2009 53: 4915-4920; published ahead of print September 8, 2009, doi:10.1128/AAC.00078-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Comparison of Assessment of Oxygen Consumption, Etest, and CLSI M38-A2 Broth Microdilution Methods for Evaluation of the Susceptibility of Aspergillus fumigatus to Posaconazole
Ricardo Araujo and Ana Espinel-Ingroff
Antimicrob. Agents Chemother. November 2009 53: 4921-4923; published ahead of print August 24, 2009, doi:10.1128/AAC.00862-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008
A. Walkty, M. DeCorby, K. Nichol, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel
Antimicrob. Agents Chemother. November 2009 53: 4924-4926; published ahead of print August 24, 2009, doi:10.1128/AAC.00786-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR
Ryoichi Hamasuna, Jørgen Skov Jensen, and Yukio Osada
Antimicrob. Agents Chemother. November 2009 53: 4938-4939; published ahead of print September 8, 2009, doi:10.1128/AAC.00724-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

In Vitro Activities of Three New Dihydrofolate Reductase Inhibitors against Clinical Isolates of Gram-Positive Bacteria
Karen E. Bowker, Patrick Caspers, Bérengère Gaucher, and Alasdair P. MacGowan
Antimicrob. Agents Chemother. November 2009 53: 4949-4952; published ahead of print September 8, 2009, doi:10.1128/AAC.00845-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Clinical Therapeutics:

Outcome of Acute Prosthetic Joint Infections Due to Gram-Negative Bacilli Treated with Open Debridement and Retention of the Prosthesis
Juan C. Martínez-Pastor, Ernesto Muñoz-Mahamud, Félix Vilchez, Sebastián García-Ramiro, Guillem Bori, Josep Sierra, José A. Martínez, Lluis Font, Josep Mensa, and Alex Soriano
Antimicrob. Agents Chemother. November 2009 53: 4772-4777; published ahead of print August 17, 2009, doi:10.1128/AAC.00188-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites
Mirja Reichel, Peter Heisig, Thomas Kohlmann, and Günter Kampf
Antimicrob. Agents Chemother. November 2009 53: 4778-4782; published ahead of print September 8, 2009, doi:10.1128/AAC.00582-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis
Juliet E. Foweraker, Christian R. Laughton, Derek F. Brown, and Diana Bilton
Antimicrob. Agents Chemother. November 2009 53: 4809-4815; published ahead of print August 24, 2009, doi:10.1128/AAC.00269-09
[Abstract] [Full Text] [PDF] [Reprints and Permissions]

Letters:

Emergence of an Enterobacter hormaechei Strain with Reduced Susceptibility to Tigecycline under Tigecycline Therapy
Claire Daurel, Anne-Lise Fiant, Sylvie Brémont, Patrice Courvalin, and Roland Leclercq
Antimicrob. Agents Chemother. November 2009 53: 4953-4954; published ahead of print September 8, 2009, doi:10.1128/AAC.01592-08
[Full Text] [PDF] [Reprints and Permissions]

TEM-168, a Heretofore Laboratory-Derived TEM β-Lactamase Variant Found in an Escherichia coli Clinical Isolate
Michael R. Mulvey and David A. Boyd
Antimicrob. Agents Chemother. November 2009 53: 4955-4956; published ahead of print August 17, 2009, doi:10.1128/AAC.00547-09
[Full Text] [PDF] [Reprints and Permissions]

High Prevalence of CTX-M-Type β-Lactamases among Clinical Isolates of Enterobacteriaceae in Bamako, Mali
Véronique Duval, Ibrahim Maiga, Aminata Maiga, Thomas Guillard, Lucien Brasme, Dominique Forte, Janick Madoux, Véronique Vernet-Garnier, and Christophe De Champs
Antimicrob. Agents Chemother. November 2009 53: 4957-4958; published ahead of print August 31, 2009, doi:10.1128/AAC.00675-09
[Full Text] [PDF] [Reprints and Permissions]

Presence of dfr6 Gene Cassette in Superintegron of Non-O1/Non-O139 Strain of Vibrio cholerae
Praveen Kumar and Sabu Thomas
Antimicrob. Agents Chemother. November 2009 53: 4959-4960; published ahead of print August 24, 2009, doi:10.1128/AAC.00540-09
[Full Text] [PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.